IRIDEX Corporation Company Profile (NASDAQ:IRIX)

About IRIDEX Corporation (NASDAQ:IRIX)

IRIDEX Corporation logoIRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:IRIX
  • CUSIP: N/A
  • Web: www.iridex.com
Capitalization:
  • Market Cap: $110.12 million
  • Outstanding Shares: 11,567,000
Average Prices:
  • 50 Day Moving Avg: $9.48
  • 200 Day Moving Avg: $9.48
  • 52 Week Range: $7.58 - $16.39
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -14.88
  • P/E Growth: -0.44
Sales & Book Value:
  • Annual Revenue: $42.8 million
  • Price / Sales: 2.57
  • Book Value: $3.25 per share
  • Price / Book: 2.93
Profitability:
  • EBITDA: ($5,810,000.00)
  • Net Margins: -37.62%
  • Return on Equity: -16.87%
  • Return on Assets: -13.86%
Debt:
  • Current Ratio: 5.61%
  • Quick Ratio: 4.15%
Misc:
  • Average Volume: 28,615 shs.
  • Beta: 1.29
  • Short Ratio: 4.92
 

Frequently Asked Questions for IRIDEX Corporation (NASDAQ:IRIX)

What is IRIDEX Corporation's stock symbol?

IRIDEX Corporation trades on the NASDAQ under the ticker symbol "IRIX."

How were IRIDEX Corporation's earnings last quarter?

IRIDEX Corporation (NASDAQ:IRIX) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.24) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.18) by $0.06. The firm earned $10 million during the quarter, compared to the consensus estimate of $10.48 million. IRIDEX Corporation had a negative net margin of 37.62% and a negative return on equity of 16.87%. View IRIDEX Corporation's Earnings History.

When will IRIDEX Corporation make its next earnings announcement?

IRIDEX Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for IRIDEX Corporation.

Where is IRIDEX Corporation's stock going? Where will IRIDEX Corporation's stock price be in 2017?

1 analysts have issued 12-month target prices for IRIDEX Corporation's shares. Their predictions range from $20.00 to $20.00. On average, they anticipate IRIDEX Corporation's share price to reach $20.00 in the next year. View Analyst Ratings for IRIDEX Corporation.

Who are some of IRIDEX Corporation's key competitors?

Who are IRIDEX Corporation's key executives?

IRIDEX Corporation's management team includes the folowing people:

  • William M. Moore Jr., Chairman of the Board, Interim President and Chief Executive Officer
  • Atabak Mokari, Chief Financial Officer, Vice President - Corporate Development
  • George R. Marcellino PhD, Director
  • Ann D. Rhoads, Director
  • Sanford Fitch, Independent Director
  • Ruediger Naumann-Etienne Ph.D., Independent Director

Who owns IRIDEX Corporation stock?

IRIDEX Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Osborne Partners Capital Management LLC (0.62%) and Ingalls & Snyder LLC (0.22%). Company insiders that own IRIDEX Corporation stock include George R Marcellino, Romeo R Dizon, Ronald Steckel, Ruediger Naumann-Etienne and William M Moore. View Institutional Ownership Trends for IRIDEX Corporation.

Who bought IRIDEX Corporation stock? Who is buying IRIDEX Corporation stock?

IRIDEX Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Osborne Partners Capital Management LLC and Ingalls & Snyder LLC. View Insider Buying and Selling for IRIDEX Corporation.

How do I buy IRIDEX Corporation stock?

Shares of IRIDEX Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IRIDEX Corporation's stock price today?

One share of IRIDEX Corporation stock can currently be purchased for approximately $9.52.


MarketBeat Community Rating for IRIDEX Corporation (NASDAQ IRIX)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about IRIDEX Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for IRIDEX Corporation (NASDAQ:IRIX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.00 (110.08% upside)
Consensus Price Target History for IRIDEX Corporation (NASDAQ:IRIX)
Price Target History for IRIDEX Corporation (NASDAQ:IRIX)
Analysts' Ratings History for IRIDEX Corporation (NASDAQ:IRIX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/21/2016Roth CapitalInitiated CoverageBuy$20.00N/AView Rating Details
1/26/2016Singular ResearchInitiated CoverageBuy$11.50N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for IRIDEX Corporation (NASDAQ:IRIX)
Earnings by Quarter for IRIDEX Corporation (NASDAQ:IRIX)
Earnings History by Quarter for IRIDEX Corporation (NASDAQ IRIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017($0.28)N/AView Earnings Details
8/3/2017Q2 2017($0.18)($0.24)$10.48 million$10.00 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.18)($0.16)$10.62 million$10.48 millionViewListenView Earnings Details
11/3/2016Q316($0.03)($0.07)$11.20 million$9.79 millionViewListenView Earnings Details
8/4/2016Q216$0.01($0.03)$11.90 million$11.90 millionViewListenView Earnings Details
5/5/2016Q116$0.04$0.01$11.88 million$11.90 millionViewListenView Earnings Details
3/3/2016Q415$0.04$0.04$11.80 million$12.10 millionViewListenView Earnings Details
11/5/2015Q315$0.04$10.10 million$9.80 millionViewListenView Earnings Details
8/6/2015Q215($0.07)$10.60 million$9.00 millionViewListenView Earnings Details
5/7/2015Q115$0.02$10.30 million$10.80 millionViewListenView Earnings Details
5/1/2014Q1$0.06$0.05$8.90 million$10.30 millionViewListenView Earnings Details
2/27/2014Q4$0.04$0.04ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IRIDEX Corporation (NASDAQ:IRIX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for IRIDEX Corporation (NASDAQ:IRIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for IRIDEX Corporation (NASDAQ:IRIX)
Insider Ownership Percentage: 5.01%
Institutional Ownership Percentage: 47.46%
Insider Trades by Quarter for IRIDEX Corporation (NASDAQ:IRIX)
Institutional Ownership by Quarter for IRIDEX Corporation (NASDAQ:IRIX)
Insider Trades by Quarter for IRIDEX Corporation (NASDAQ:IRIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017William M MooreChairmanBuy1,800$9.42$16,956.00View SEC Filing  
3/15/2017Romeo R DizonInsiderSell2,811$13.16$36,992.76View SEC Filing  
11/16/2016Romeo R DizonInsiderSell584$16.04$9,367.36View SEC Filing  
9/12/2016Romeo R DizonInsiderSell125$15.00$1,875.00View SEC Filing  
9/7/2016Ruediger Naumann-EtienneDirectorSell9,513$14.75$140,316.75View SEC Filing  
9/2/2016Ruediger Naumann-EtienneDirectorSell2,513$14.73$37,016.49View SEC Filing  
8/23/2016Romeo R DizonInsiderSell875$14.52$12,705.00View SEC Filing  
8/19/2016Romeo R DizonInsiderSell7,896$13.52$106,753.92View SEC Filing  
8/16/2016George R MarcellinoDirectorSell2,513$13.57$34,101.41View SEC Filing  
8/16/2016Romeo R DizonInsiderSell839$13.70$11,494.30View SEC Filing  
6/6/2016Ronald SteckelVPSell625$13.52$8,450.00View SEC Filing  
5/17/2016Ronald SteckelVPSell4,583$12.81$58,708.23View SEC Filing  
3/8/2016Ronald SteckelVPSell12,000$10.45$125,400.00View SEC Filing  
11/19/2015William M MooreCEOBuy10,000$9.83$98,300.00View SEC Filing  
9/25/2015Associates & Paragon A ParagonMajor ShareholderBuy52,042$7.05$366,896.10View SEC Filing  
9/10/2015Associates & Paragon A ParagonMajor ShareholderBuy11,866$6.95$82,468.70View SEC Filing  
9/4/2015Associates & Paragon A ParagonMajor ShareholderBuy10,304$6.81$70,170.24View SEC Filing  
9/2/2015Ronald SteckelVPSell1,875$6.80$12,750.00View SEC Filing  
8/21/2015Associates & Paragon A ParagonMajor ShareholderBuy20,651$7.16$147,861.16View SEC Filing  
8/19/2015James H. MackanessCFOSell2,373$7.15$16,966.95View SEC Filing  
8/19/2015Ronald SteckelVPSell1,751$7.14$12,502.14View SEC Filing  
8/18/2015James H. MackanessCFOSell2,627$7.10$18,651.70View SEC Filing  
8/17/2015James H. MackanessCFOSell2,235$7.05$15,756.75View SEC Filing  
8/14/2015James H MackanessCFOSell7,765$6.99$54,277.35View SEC Filing  
8/14/2015Ronald SteckelVPSell1,458$7.00$10,206.00View SEC Filing  
7/24/2015Associates & Paragon A ParagonMajor ShareholderBuy40,403$7.01$283,225.03View SEC Filing  
6/17/2015Ronald SteckelVPSell1,666$8.77$14,610.82View SEC Filing  
5/20/2015James H MackanessCFOSell2,000$9.80$19,600.00View SEC Filing  
5/18/2015Ronald SteckelVPSell1,667$9.33$15,553.11View SEC Filing  
4/20/2015Ronald SteckelVPSell1,447$9.79$14,166.13View SEC Filing  
4/17/2015Ronald SteckelVPSell1,667$9.86$16,436.62View SEC Filing  
3/17/2015Ronald SteckelVPSell11,358$10.08$114,488.64View SEC Filing  
3/10/2015Ronald SteckelVPSell1,250$10.03$12,537.50View SEC Filing  
2/17/2015Ronald SteckelVPSell1,650$9.79$16,153.50View SEC Filing  
1/20/2015Ronald SteckelVPSell1,650$9.03$14,899.50View SEC Filing  
12/17/2014Ronald SteckelVPSell1,650$8.52$14,058.00View SEC Filing  
11/17/2014Ronald SteckelVPSell1,650$8.28$13,662.00View SEC Filing  
11/6/2014William M MooreDirectorBuy5,000$7.79$38,950.00View SEC Filing  
10/12/2014Catalyst Fund Ix L.P BluelineDirectorBuy17,237$8.11$139,792.07View SEC Filing  
10/10/2014Catalyst Fund Ix L.P BluelineDirectorBuy12,798$8.02$102,639.96View SEC Filing  
9/5/2014Catalyst Fund Ix L.P BluelineDirectorBuy8,432$7.99$67,371.68View SEC Filing  
8/29/2014Catalyst Fund Ix L.P BluelineDirectorBuy4,272$7.92$33,834.24View SEC Filing  
8/22/2014James B HawkinsDirectorSell600$8.03$4,818.00View SEC Filing  
8/18/2014Ronald SteckelVPSell1,650$8.00$13,200.00View SEC Filing  
8/15/2014James B HawkinsDirectorSell14,400$8.10$116,640.00View SEC Filing  
8/14/2014James B HawkinsDirectorSell2,714$8.08$21,929.12View SEC Filing  
8/13/2014James B HawkinsDirectorSell9,786$8.11$79,364.46View SEC Filing  
8/11/2014Garrett A GarrettsonDirectorSell2,810$8.30$23,323.00View SEC Filing  
7/31/2014Ronald SteckelVPSell761$8.00$6,088.00View SEC Filing  
7/21/2014James H MackanessCFOSell1,000$7.62$7,620.00View SEC Filing  
6/23/2014James H MackanessCFOSell2,000$8.24$16,480.00View SEC Filing  
6/17/2014Ronald SteckelVPSell1,650$8.20$13,530.00View SEC Filing  
6/6/2014Catalyst Fund Ix L.P BluelineDirectorBuy7,390$8.32$61,484.80View SEC Filing  
6/3/2014William M MooreCEOBuy5,000$8.48$42,400.00View SEC Filing  
5/21/2014James H MackanessCFOSell3,000$8.73$26,190.00View SEC Filing  
5/19/2014Ronald SteckelVPSell1,650$8.82$14,553.00View SEC Filing  
5/9/2014William M MooreCEOBuy5,000$8.40$42,000.00View SEC Filing  
4/22/2014James H MackanessCFOSell4,000$8.74$34,960.00View SEC Filing  
4/17/2014Ronald SteckelVPSell1,650$8.88$14,652.00View SEC Filing  
3/21/2014James H MackanessCFOSell4,000$9.03$36,120.00View SEC Filing  
3/17/2014Ronald SteckelVPSell1,650$9.07$14,965.50View SEC Filing  
2/18/2014Ronald SteckelVPSell1,650$8.60$14,190.00View SEC Filing  
1/17/2014Ronald SteckelVPSell1,650$10.42$17,193.00View SEC Filing  
12/17/2013Ronald SteckelVPSell1,650$8.56$14,124.00View SEC Filing  
12/2/2013James H MackanessCFOSell10,000$10.52$105,200.00View SEC Filing  
9/6/2013Ruediger Naumann-EtienneDirectorBuy3,600$5.99$21,564.00View SEC Filing  
8/9/2013William M MooreCEOBuy10,000$5.88$58,800.00View SEC Filing  
6/19/2013Eduardo AriasVPSell22,768$5.43$123,630.24View SEC Filing  
6/18/2013James H MackanessCFOSell19,862$4.58$90,967.96View SEC Filing  
6/17/2013Eduardo AriasVPSell4,532$5.39$24,427.48View SEC Filing  
6/14/2013James H MackanessCFOSell10,568$5.38$56,855.84View SEC Filing  
6/13/2013James H MackanessCFOSell1,400$5.30$7,420.00View SEC Filing  
6/11/2013Eduardo AriasVPSell1,000$5.61$5,610.00View SEC Filing  
6/11/2013James H MackanessCFOSell1,200$5.61$6,732.00View SEC Filing  
6/10/2013Eduardo AriasVPSell2,400$5.38$12,912.00View SEC Filing  
6/10/2013James H MackanessCFOSell6,970$5.36$37,359.20View SEC Filing  
6/6/2013William M MooreCEOBuy2,000$5.42$10,840.00View SEC Filing  
5/17/2013Eduardo AriasVPSell10,000$6.30$63,000.00View SEC Filing  
3/8/2013Ruediger Naumann-EtienneDirectorBuy2,400$4.80$11,520.00View SEC Filing  
3/7/2013William M MooreCEOBuy10,000$4.66$46,600.00View SEC Filing  
9/6/2012William M MooreCEOBuy10,000$3.76$37,600.00View SEC Filing  
8/15/2012Catalyst Fund Ix L.P BluelineMajor ShareholderBuy60,900$3.19$194,271.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for IRIDEX Corporation (NASDAQ:IRIX)
Latest Headlines for IRIDEX Corporation (NASDAQ:IRIX)
Source:
Loading headlines, please wait.

Social

Chart

IRIDEX Corporation (IRIX) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.